AKT1 and breast carcinoma: Moreover, ENO1 promotes the occurrence of various cancers, including breast cancer, through the PI3K/AKT pathway, and the PI3K/AKT pathway is also inhibited in liver cancer cells after inhibiting ENO1 [12].